US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating the Healthcare Sector with High ROE and Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $12.86 billion, the Cincinnati-based company is..

Exelixis, Inc. (EXEL) Stock Analysis: Unveiling a 16.78% Potential Upside Amidst Robust Drug Pipeline

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, has piqued the interest of individual investors with its promising drug pipeline and substantial potential upside. With a market..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings and 26.91% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biotechnology company, presents a compelling opportunity for investors seeking growth in the healthcare sector. With a market capitalization of $12.01 billion, Ascendis is..

Eli Lilly and Company (LLY) Stock Analysis: Growth Potential and Analyst Ratings Indicate 27.74% Upside

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, particularly within the general drug manufacturing industry. With a staggering market capitalization of $628.62 billion,..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Analyzing a Potential 97% Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD) has captured the attention of investors with its ambitious foray into precision oncology, specifically targeting RAS-addicted cancers—a challenging frontier in biotechnology. With a market cap..

Encompass Health Corporation (EHC) Stock Analysis: A Growing Giant in Healthcare with 12.77% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare sector, providing essential post-acute healthcare services across the United States and Puerto Rico. With a market capitalization..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Modest Growth and Dividend Appeal

GSK plc (NYSE: GSK), a stalwart in the global healthcare sector, commands significant attention with its robust market capitalization of $79.34 billion. Operating in the drug manufacturing industry, GSK has..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating a 38% Potential Upside with Strong Buy Ratings

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, specializes in diagnostics and research with a strong focus on cancer screening and diagnostic test products. With a..

Incyte Corporation (INCY): An Investor Outlook with 16.50% Revenue Growth and Promising Drug Pipeline

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust revenue growth and diverse therapeutic portfolio. Headquartered in Wilmington, Delaware,..

DaVita Inc. (DVA) Stock Analysis: Exploring the 13% Upside in Healthcare Giant

DaVita Inc. (NYSE: DVA), a prominent name in the healthcare sector, stands out as a key player in the medical care facilities industry. With a market capitalization of $9.68 billion,..

Amgen Inc. (AMGN) Stock Analysis: Strong Dividend Yield and Innovative Portfolio Drive Investor Interest

Amgen Inc. (NASDAQ: AMGN), a titan within the healthcare sector, stands as a formidable player in the general drug manufacturing industry. With a robust market capitalization of approximately $159.61 billion,..

McKesson Corporation (MCK) Stock Analysis: Exploring a 17% Potential Upside Amid Robust Revenue Growth

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, is an intriguing prospect for investors looking for exposure to the medical distribution industry. With a market capitalization of $83.72..

Zoetis Inc. (ZTS) Stock Analysis: A 23.69% Potential Upside for Investors in Animal Health

Zoetis Inc. (NYSE: ZTS), a leading player in the animal health sector, offers a compelling investment opportunity with a potential upside of 23.69%, according to recent analyst ratings. Headquartered in..

Illumina, Inc. (ILMN) Investor Outlook: Can This Genomics Giant Overcome a 4.8% Revenue Decline?

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the genomics and diagnostics sector, presents a complex picture for investors. The company’s current market capitalization sits at $15.85 billion, reflecting its..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 4.24% Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a leader in the Health Information Services industry, has caught the attention of investors with its compelling growth metrics and a promising outlook. The San Francisco-based..

Insulet Corporation (PODD) Stock Analysis: Revenue Growth and Analyst Ratings Signal Promising Future

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) to be a compelling prospect, thanks to its innovative advances in insulin delivery systems and..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and a Promising 12.53% Upside

For investors with an eye on the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) presents an intriguing opportunity. With a market capitalization of $184.66 billion, this United States-based leader..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with 4.62% Potential Upside

Medtronic plc (NYSE: MDT), a titan in the medical devices sector, continues to be a compelling choice for investors seeking stability and growth in the healthcare industry. With its global..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a Strong Buy Consensus with 8.45% Potential Upside

For individual investors eyeing opportunities in the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents a compelling case. As a leader in Diagnostics & Research, Labcorp not only offers a..

Mettler-Toledo International (MTD) Stock Analysis: Evaluating the 3.90% Revenue Growth and Analyst Ratings

Mettler-Toledo International Inc. (NYSE: MTD), a stalwart in the diagnostics and research industry, continues to capture investor attention with its robust market presence and consistent revenue growth. As a leader..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds